Nuts naturally help regulate appetite, balance blood glucose levels, and keep you fuller for longer (6)
CMS Issues Coverage Guidance on GLP-1 Anti-Obesity Drugs: Implications for Health Plans Posted on April 5, 2024 CMS Issued Coverage Guidance on GLP-1 Anti-Obesity Drugs Requiring Considerations for Health Plans GLP-1s (glucagon-like peptide 1 agonist) came up in the news again after the Centers for Medicare and Medicaid Services (CMS) issued coverage guidance on GLP-1 anti-obesity drugs with expanded indications on March 20, 2024.* Since the inception of Medicare Part D, drugs used for weight loss have been excluded from basic coverage
Li CJ, Yu Q, Yu P, Yu TL, Zhang QM, Lu S, et al
Keto can also cause brain fog, fatigue, and irritability as the body adjusts to consuming fewer carbs, says Cleveland Clinic
That status changed in December 2025 with the FDA approval of an oral version of Wegovy (also manufactured by Novo Nordisk)